Anthony Fauci
Anthony Fauci
Anthony Stephen "Tony" Fauciis an American immunologist who has made substantial contributions to HIV/AIDS research and other immunodeficiencies, both as a scientist and as the head of the National Institute of Allergy and Infectious Diseases...
NationalityAmerican
ProfessionScientist
Date of Birth24 December 1940
CountryUnited States of America
continued fix health ongoing perpetual pipeline problem public resistance resistant serious
Antibiotics are a very serious public health problem for us, and it's getting worse. Resistant microbes outstrip new antibiotics. It's an ongoing problem. It's not like we can fix it, and it's over. We have to fight continued resistance with a continual pipeline of new antibiotics and continue with the perpetual challenge.
allergy basic clinical diseases health infectious institute national treatment
The National Institute of Allergy and Infectious Diseases is an institute of the National Institutes of Health that is responsible predominantly for basic and clinical research in the diagnosis, treatment and prevention of immunologic and infectious diseases.
care general health low people sars virus vulnerable
Some of the most vulnerable people to getting the SARS virus are health care providers. The general public, walking in the street, there is really not that much risk at all. It's a very, very low risk - a very, very low risk.
assume becoming events giving health officials public scenario signs
We as public health officials ... must assume the worst-case scenario and H5N1 is now giving us a lot of signs that is becoming a little more worrisome, if not a lot a more worrisome, because of the events that are going on,
giving healthy disease
Investigating rare diseases gives researchers more clues about how the healthy immune system functions.
came diminished hidden levels pool three virus weeks within
Even in individuals in which we diminished the pool of the reservoir, the hidden reservoir, to levels that were essentially non-detectable ... the virus came right back within two to three weeks in essentially everyone.
available currently eliminate eradicate given virus
It does tell us is that given the currently available regimens that we have of anti-viral drugs that we are not going to eliminate or eradicate the virus from individuals,
true
We have to see if it is true and if we can do anything about it,
came fact hoped line percent response
We hoped to see a 75 percent response rate, but the fact it came in at 50 percent is not way out of line for our expectations.
course early
We now know that these reservoirs are established very early in the course of infection.
albeit good high immune news spur vaccine
We have a vaccine we know can spur an immune response, albeit at very high doses. We're going in the right direction. The sobering news is we have a long way to go. So it's muted good news.
alter blunt burst course early enormous initial prevent production virus
Vaccines, if they can blunt that initial, enormous burst of virus production early on, even if it doesn't prevent initial infection, may dramatically alter the course of infection,
direct elicit factor guarantee identify particular protecting response vaccine
If we could identify what that factor is -- and there's no guarantee we will, but if we can -- then one could direct your vaccine to elicit a response of that particular factor that is protecting them.
both private resulted today vaccines
Many vaccines in use today resulted from both government-sponsored and private research.